Kamoltham T, Singhsa J, Promsaranee U, Sonthon P, Mathean P, Thinyounyong W
Provincial Public Health Office of Phetchabun, Bungsampan, Thailand.
Bull World Health Organ. 2003;81(5):375-81.
A five-year project to prevent human deaths from rabies in Phetchabun Province, Thailand involved increasing accessibility of post-exposure treatment with the Thai Red Cross intradermal (2-2-2-0-1-1) regimen for humans exposed to potentially and confirmed rabid animals; intensifying documentation of post-exposure treatment; increasing educational awareness through advocacy in provincial schools, television programmes, and newspapers; reducing canine rabies by monitoring the dog population and implementing vaccination and sterilization programmes; increasing the cooperation between the Ministries of Public Health, Agriculture, and Education on a provincial level; and assessing the impact of the programme through intensified follow-up of patients exposed to suspected and laboratory-confirmed rabid animals. Between 1996 and 2001, 10350 patients received post-exposure treatment; 7227 of these received the Thai Red Cross intradermal regimen. Fewer than 3% of exposed patients received rabies immunoglobulin. Seventy-three percent of all patients presented with WHO category III exposures. In a retrospective study, 188 patients exposed to laboratory-confirmed rabid animals were followed to determine their health status. Of these patients, 20 received the intramuscular Essen regimen and 168 the Thai Red Cross intradermal regimen (148 received 0.1 ml purified chick embryo cell rabies vaccine, 10 received 0.1 ml purified vero cell rabies vaccine, and 10 received 0.2 ml purified duck embryo cell rabies vaccine). All patients were alive one year after exposure. Two human deaths occurred in the first two years of the programme - neither patient had received vaccine or rabies immunoglobulin after exposure. No deaths occurred during the last three years of the programme, which indicated that the programme was successful.
泰国彭世洛府开展了一项为期五年的预防狂犬病致人死亡项目,内容包括提高泰国红十字会针对暴露于潜在感染和确诊感染狂犬病动物的人群采用皮内注射(2-2-2-0-1-1)方案进行暴露后治疗的可及性;加强暴露后治疗的记录工作;通过在省级学校、电视节目和报纸上进行宣传提高教育意识;通过监测犬类数量并实施疫苗接种和绝育计划来减少犬类狂犬病;加强省级公共卫生部、农业部和教育部之间的合作;以及通过加强对暴露于疑似和实验室确诊狂犬病动物的患者的随访来评估该项目的影响。1996年至2001年期间,10350名患者接受了暴露后治疗;其中7227人接受了泰国红十字会皮内注射方案。暴露患者中接受狂犬病免疫球蛋白治疗的不到3%。所有患者中有73%属于世界卫生组织III级暴露。在一项回顾性研究中,对188名暴露于实验室确诊狂犬病动物的患者进行随访以确定其健康状况。这些患者中,20人接受了肌内注射埃森方案,168人接受了泰国红十字会皮内注射方案(148人接受0.1毫升纯化鸡胚细胞狂犬病疫苗,10人接受0.1毫升纯化 vero 细胞狂犬病疫苗,10人接受0.2毫升纯化鸭胚细胞狂犬病疫苗)。所有患者在暴露后一年均存活。该项目开展的头两年有两人死亡——两名患者暴露后均未接受疫苗或狂犬病免疫球蛋白治疗。该项目最后三年未发生死亡病例,这表明该项目取得了成功。